Goldman Sachs Group vs. JPMorgan Chase: Which Financial Stock Is a Better Buy in 2026?

In FY 2025, JPMorgan reported $279.7B in revenue and $57.0B in net income, versus Goldman Sachs’ $125.1B and $17.2B; revenue declined 1.4% at Goldman and grew 3.3% at JPMorgan. JPMorgan had higher reported net and average operating margins, while Goldman had lower valuation multiples in the article’s comparisons and a 2.1% dividend yield versus JPMorgan’s 1.9%. The comparison favors Goldman for value- or income-oriented investors, while presenting JPMorgan as the more profitable, diversified option; both reported negative free cash flow for FY 2025.

Analysis

The key exposure is earnings mix, not the small valuation gap. Goldman has greater operating leverage to a recovery in M&A, underwriting and trading; that can turn into faster earnings growth, but also leaves estimates more vulnerable if deal activity or risk appetite stalls. JPMorgan’s broader franchise should dampen that cyclicality, while its scale may help absorb technology, compliance and cybersecurity spending. That makes JPM the more resilient core holding and GS the higher-beta expression of improving capital-markets activity.

The article’s valuation case is not robust enough to drive a switch: its forward P/E comparison and later P/E figures are not clearly on the same basis, and the reported difference is modest. Bank current ratios and free-cash-flow figures are also poor standalone liquidity signals because deposit and lending balance sheets do not behave like industrial-company working capital. Verify comparable earnings definitions, capital ratios, credit costs and valuation dates before acting.

Over the next 1–3 months, deal pipeline commentary, underwriting volumes and trading conditions are the more useful catalysts for GS; loan-loss provisions, deposit pricing and expense guidance matter more for JPM. Over 6–18 months, a sustained deal-cycle recovery could narrow JPM’s resilience premium, while weaker credit or tighter capital requirements could pressure both. The card-program transitions are not, by themselves, evidence of a material earnings change; verify remaining balances, transfer economics and any associated costs.

Key Decisions for Investors

• Prefer JPM as the lower-cyclicality core bank exposure; do not rotate into GS solely on the article’s small, internally inconsistent valuation advantage.
• Treat GS as a tactical, higher-beta position only if management commentary and subsequent results confirm improving advisory and underwriting activity without deterioration in risk appetite. Reassess if deal activity weakens or earnings guidance is cut.
• Watch for a relative-value entry rather than initiating a forced pair trade: compare GS and JPM on a consistent forward-earnings basis and against their own historical relative valuation. If that spread does not offer a clear margin of safety, remain unpaired.
• Before using liquidity or balance-sheet claims in sizing, verify regulatory capital and liquidity measures, credit-loss trends, deposit costs, and the scope and economics of the AAPL and GM card transitions.